OMDA
Omada Health · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +27.2% ·
net new positions +20.0%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.60M | n/a | $102.49M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | Point72 Asset Management ✦ | 675.50K | New | $12.36M | 0.0% | New | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (passive) | 300.00K | New | $5.49M | 0.0% | New | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 278.84K | New | $5.10M | 0.0% | New | 1 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 208.29K | New | $3.81M | 0.0% | New | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passive) | 65.00K | n/a | $1.19M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 7 | Soros Fund Management ✦ | 35.00K | New | $640,500 | 0.0% | New | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 34.80K | New | $636,803 | 0.0% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 10.00K | New | $183,000 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $12.36M | 0.0% |
| Norges Bank | $5.49M | 0.0% |
| Millennium Management | $5.10M | 0.0% |
| Citadel Advisors | $3.81M | 0.0% |
| Soros Fund Management | $640,500 | 0.0% |
| Geode Capital Management | $636,803 | 0.0% |
| Two Sigma Investments | $183,000 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 138 holders, 47.82M shares, $543.52M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 12.94K sh · $266,753
Officer, Director · 4.31K sh · $90,163
Officer, Director · 1.40K sh · $31,628
Officer · 400 sh · $9,013
Officer · 3.64K sh · $79,193
Officer, Director · 13.56K sh · $295,569
Officer · 600 sh · $13,510
Officer · 6.20K sh · $135,130
Officer · 644 sh · $13,995
Officer, Director · 5.60K sh · $135,901
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology